Baker Bros. Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.25M | Hold |
4,004,756
| – | – | 0.09% | 55 |
|
|
2025
Q1 | $5.57M | Hold |
4,004,756
| – | – | 0.06% | 57 |
|
|
2024
Q4 | $6.93M | Hold |
4,004,756
| – | – | 0.07% | 63 |
|
|
2024
Q3 | $8.05M | Hold |
4,004,756
| – | – | 0.08% | 60 |
|
|
2024
Q2 | $8.97M | Hold |
4,004,756
| – | – | 0.11% | 52 |
|
|
2024
Q1 | $11.5M | Hold |
4,004,756
| – | – | 0.14% | 46 |
|
|
2023
Q4 | $7.09M | Buy |
4,004,756
+1,500,000
| +60% | +$2.66M | 0.08% | 58 |
|
|
2023
Q3 | $7.92M | Buy |
+2,504,756
| New | +$7.92M | 0.05% | 52 |
|